Hollow fiber bioreactor: flexibility across modalities

Mindy Miller currently serves as the lead research scientist within Terumo Blood and Cell Technologies' Cell Therapy Technologies team. She holds a doctorate in Immunology from University of Missouri and conducted post-doctoral studies at University of Missouri, as well as National Jewish Health in Denver, CO.

Mindy’s expertise has focused on the development of immune cells in the context of autoimmunity, allergy and asthma, and pulmonary wound healing. She has authored multiple scientific publications, obtained independent funding, and is the recipient of the Young Investigator Award from the American Association of Immunologists.

Annie is currently a Field Application scientist, leading projects on the Quantum Cell Expansion System and FINIA Fill and Finish System. She has spent most of her career in the biotechnology industry, beginning at Seattle Genetics where she was part of the BLA submission and FDA approval of ADCETRIS^®, an antibody drug conjugate for CD30+ blood cancer. She then shifted focus into immunotherapy and contributed to the development of a CAR-T program.

Nate has more than a decade of experience optimizing parameters for cell and gene therapy production and scale-up. He has specialized expertise in hollow fiber bioreactor process development for a range of cell types aimed at various applications in regenerative medicine and immunotherapy. He is a two-time National Science Foundation fellow and has a passion for teaching and communicating science to a wide range of audiences from established professionals to middle and high school students who are just beginning their scientific journey.